Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K110482
    Manufacturer
    Date Cleared
    2011-03-18

    (28 days)

    Product Code
    Regulation Number
    892.1550
    Why did this record match?
    Device Name :

    PROSOUND C3 / C3 CV ULTRASOUND SYSTEMS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Aloka ProSound C3 is a general purpose Ultrasound System intended for use by a qualified physician for evaluation by ultrasound imaging or fluid flow analysis of the human body. Specific clinical applications and exam types include: Fetal, Abdominal, Intra-operative (abdominal, thoracic and PV); Pediatrics, Small Organ (Breast, testes, thyroid); Neonatal and Adult Cephalic; Trans-rectal and Trans-vaginal; Musculo-skeletal (Conventional and Superficial); Cardiac (Adult & Pediatric); Peripheral Vascular.

    The Aloka ProSound C3cv is a general purpose Ultrasound System intended for use by a qualified physician for evaluation by ultrasound imaging or fluid flow analysis of the human body. Specific clinical applications and exam types include: Fetal, Abdominal, Intra-operative (abdominal, thoracic and PV); Pediatrics, Small Organ (Breast, testes, thyroid); Neonatal and Adult Cephalic; Trans-rectal and Trans-vaginal; Musculo-skeletal (Conventional and Superficial); Cardiac (Adult & Pediatric); Peripheral Vascular.

    The subject-modified device is a general purpose Ultrasound System intended for use by a qualified physician for evaluation by ultrasound imaging or fluid-flow analysis of the human body. Specific clinical applications and exam types include: Fetal/OB; Abdominal (GYN & Urology); Intra-operative (abdominal, thoracic and PV); Laparoscopic; Pediatric; Small Organ (breast, testes, thyroid), Neonatal and Adult Cephalic; Transrectal and Transvaginal; Musculo-skeletal (Conventional and Superficial); Cardiac (adult & pediatric); Peripheral Vascular.

    The subject-modified device is a general purpose Ultrasound System intended for use by a qualified physician for evaluation by ultrasound imaging or fluid-flow analysis of the human body. Specific clinical applications and exam types include: Fetal/OB; Andominal (GYN & Urology); Intra-operative (abdominal, thoracic and PV); Laparoscopic; Pedintria; Small Organ (breast, testes, thyroid), Neonatal and Adult Cephalic; Transrects | and Transvaginal; Musculo-skeletal (Conventional and Superficial); Cardiac (adult & pediatric); Peripheral Vascular.

    Device Description

    The ProSound C3 is a modified version of the Echo/t3000 Ultrasound System. The modifications include a change in the Product Label (of both the systems and the transducers), addition of Foreign language support (French, German, Italian, and Spanish), a slight modification of Transmit circuitry, providing a slightly different acoustic profile and the introduction of a spatial compounding feature called OMNIBeam.

    The design and construction of the ProSound C3 is similar to the Terason™ Echo/t3000 Ultrasound system. These systems utilize a laptop computer running Windows to run the ultrasound application and a custom designed engine for control of the acoustic array and processing of the return echoes. The engine is housed in a compartment that is attached to the bottom of the laptop.

    The ProSound C3cv is a modified version of the Echo/t3000 Ultrasound System. The modifications include a change in the Product Label (of both the systems and the transducers), addition of Foreign language support (French, German, Italian, and Spanish) and the introduction of a spatial compounding feature called OmniBeam.

    The design and construction of the ProSound C3cv is similar to the Terason™ Echo/t3000 Ultrasound system. These systems utilize a laptop computer running Windows to run the ultrasound application and a custom designed engine for control of the acoustic array and processing of the return echoes. The engine is housed in a compartment that is attached to the bottom of the laptop.

    AI/ML Overview

    The provided text describes modifications to an ultrasound system (Aloka ProSound C3 and C3cv) and its transducers, and references various non-clinical tests to demonstrate compliance with general safety and performance standards. However, it does not contain information about acceptance criteria for specific imaging performance metrics, nor does it describe studies with sample sizes, expert ground truth, or comparative effectiveness with human readers using AI.

    The document is a 510(k) summary, which typically focuses on demonstrating substantial equivalence to a predicate device by showing that the new device is as safe and effective. This is often achieved through non-clinical testing against recognized standards rather than extensive clinical performance studies as would be required for novel devices or AI systems making diagnostic claims.

    Therefore, most of the requested information cannot be extracted from this document because such studies were not conducted or described in this regulatory filing.

    Here's a breakdown of what can be inferred or directly stated from the provided text, and what is missing:


    Acceptance Criteria and Device Performance

    The document does not specify quantitative acceptance criteria for image quality or diagnostic performance, nor does it report specific device performance metrics in comparison to such criteria. Instead, compliance is demonstrated through adherence to recognized international and national standards for medical electrical equipment and ultrasonic devices.

    Acceptance Criteria CategoryAcceptance Criteria (from document)Reported Device Performance (from document)
    General SafetyIEC 60601-1: Medical Electrical Equipment Part 1: General Requirements for Safety.The ProSound C3/C3cv systems have been "tested for compliance" with this standard, with specific Intertek Test Record Numbers (e.g., 3157931BOX-001B for C3, 3157931BOX-005A for C3cv) referenced as proof. This implies successful completion of the tests and meeting the requirements, but no quantitative performance data is provided here.
    Electrical Systems SafetyIEC 60601-1-1: Medical Electrical Equipment Part 1: General Requirements for Safety Collateral Standard: Safety Requirements for Medical Electrical Systems."Tested for compliance" with specific Intertek Project references (e.g., 9157933BOX-002A for C3, 9157933BOX-002B for C3cv). Implies successful completion.
    IEC 60601-1-4 (2000): Collateral Standard: Safety Requirements for Medical Electrical Systems. (Note: This is a duplicate or very similar standard to IEC 60601-1-1 listed directly above it in the original text, but listed separately)"Tested for compliance" with specific Intertek Project references (e.g., 9157933BOX-003A for C3, 9157933BOX-003B for C3cv). Implies successful completion.
    Ultrasonic Safety & PerformanceIEC 60601-2-37 / EN60601-2-37: Medical Electrical Equipment Part 2: Particular requirements for the safety of ultrasonic medical diagnostic and monitoring equipment."Tested for compliance" for various transducer models, with specific Intertek Report Numbers referenced for each (e.g., UST-TL01, UST-TL02, UST-TC04, UST-TC05, UST-TC06, UST-TL07 for C3; UST-TL01, UST-TL02, UST-TS03, UST-TC04, UST-TC06, UST-TI09 for C3cv). This indicates that the acoustic output and other safety aspects of the transducers meet the specified requirements. No specific quantitative performance data is provided here.
    Acoustic Output DisplayNEMA UD 3: Acoustic Output Display.User Guide (16-5001) for ProSound C3/C3cv is referenced, indicating compliance with NEMA UD 3 for acoustic output display. This is a standard for how acoustic output is presented to the user, not performance itself.
    BiocompatibilityISO 10993 Part 5 and Part 10."Biocompatibility reports for all transducers included in this submission" are mentioned, indicating compliance.

    Missing Information (Not found in the provided document):

    • Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective): No information on test sets (beyond compliance testing) for clinical performance.
    • Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable as no clinical test sets with ground truth are described.
    • Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable.
    • If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. AI assistance is not mentioned as a feature of this ultrasound system. The "OMNIBeam" feature is spatial compounding, which is an image processing technique, not an AI diagnostic aid.
    • If a standalone (i.e. algorithm only without human-in-the loop performance) was done: Not applicable. This is a diagnostic ultrasound system (hardware and associated software), not a standalone diagnostic algorithm.
    • The type of ground truth used (expert consensus, pathology, outcomes data, etc): Not applicable. The "ground truth" demonstrated is compliance with engineering and safety standards.
    • The sample size for the training set: Not applicable. The document does not describe an AI/machine learning component that would require a training set. The software modifications are for foreign language support and spatial compounding (OMNIBeam).
    • How the ground truth for the training set was established: Not applicable.

    Conclusion:

    The provided 510(k) summary focuses on demonstrating substantial equivalence through compliance with established medical device safety and performance standards for an ultrasound system and its transducers. This type of regulatory submission does not typically include detailed clinical performance studies, ground truth establishment, or AI-specific assessment criteria as would be expected for novel diagnostic algorithms. The modifications primarily concern product labeling, foreign language support, a minor transmit circuitry change, and the addition of a spatial compounding feature (OMNIBeam), all of which are assessed for safety and basic functionality rather than intricate diagnostic performance studies with expert ground truth.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1